25 of the Best Oncologists Near Me

Sumreen Majeed is a Hematologist and an Oncologist practicing medicine in Bay Shore, New York. Dr. Majeed is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Majeed is currently accepting new patients.

Aleksander Chojecki is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Chojecki is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Chojecki is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, and American Board Of Internal Medicine, Medical Oncology. Dr. Chojecki is currently accepting new patients.

Michelle Kuznicki is an Oncologist practicing medicine in Cleveland, Ohio. Dr. Kuznicki is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Salpingo-Oophorectomy. Dr. Kuznicki is board certified in American Board Of Obstetrics And Gynecology, 2023. Dr. Kuznicki is currently accepting new patients.

Jennifer Crook is an Oncologist practicing medicine in Winston Salem, North Carolina. Dr. Crook is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Crook is currently accepting new patients.

Ubaid Nawaz is a Hematologist and an Oncologist practicing medicine in Kenosha, Wisconsin. Dr. Nawaz is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Nawaz is board certified in American Board Of Internal Medicine, Hematology. Dr. Nawaz is currently accepting new patients.

Jaime Mullin, DO, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Mullin is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy. Dr. Mullin is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Mullin is currently accepting new patients.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila-Brebenel is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Vintila-Brebenel is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Vintila-Brebenel is currently accepting new patients.

Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.

Jamie Chaft is an Oncologist practicing medicine in New York, New York. Dr. Chaft is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Chaft is currently accepting new patients.

It’s important that the treatment experience is as personal and comfortable as possible for every family. Our department has its own Family Advisory Council whose input helped bring lots of improvements – like room service, refrigerators, prayer groups, better food, and better access to social support. Making life easier for these families is a huge priority for me. Even sick kids are kids at heart (as I am), just looking for a smile, some fun, a connection with the team members who take care of them. I make it my business to make life better for these kids and their families – as a doctor and through research into promising new drugs. I’m a firm believer in clinical trials. In fact, about 80% of our patients are enrolled in clinical trials through the Nemours Center for Cancer and Blood Disorders, and the Nemours Center for Childhood Cancer Research, where I’m director of both. This number is much higher than for adults with cancer, and much higher for children with other kinds of diseases. We also participate in the national Pediatric Preclinical Testing Program, which makes new therapies available for kids sooner. In our department, participating in clinical trials and research studies is the standard of our family-centered care. Dr. Kolb is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Leukemia, Rhabdomyosarcoma, and Bone Marrow Transplant. Dr. Kolb is currently accepting new patients.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy. Dr. Bergsland is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Bergsland is currently accepting new patients.

Jason Chesney is an Oncologist practicing medicine in Louisville, Kentucky. Dr. Chesney is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Melanoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. Dr. Chesney is currently accepting new patients.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon-Ching is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Prostate Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.

Dr. Lang is a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Madison, WI. He specializes in genitourinary cancer and medical oncology. Dr. Lang is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Nasopharyngeal Carcinoma, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Lang is board certified in Internal Medicine and Medical Oncology. Dr. Lang is currently accepting new patients.

Practice philosophy:My goal is to provide excellent, comprehensive care for cancer patients in a caring and compassionate manner. My philosophy is to utilize the entire care team and partner with patients and families to determine and deliver the best management strategy that meets the goals and needs of the individual patient. Dr. Hubbard is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Hepato-Pancreato-Biliary Surgery. Dr. Hubbard is board certified in American Board Of Internal Medicine,2010 and Medical Oncology. Dr. Hubbard is currently accepting new patients.

Dr. Arash Rezazadeh Kalebasty is a board-certified UCI Health medical oncologist who specializes in the diagnosis and treatment of genitourinary cancers. His clinical interests include immunotherapy and orther targeted therapies to treat cancers of the prostate, bladder, kidney and testes.He earned his medical degree at Shahid Beheshti University of Medical Sciences in Tehran, Iran. He completed a residency in internal medicine and a fellowship in medical oncology and hematology at Kentucky’s University of Louisville School of Medicine.Rezazadeh has served as principal investigator in numerous clinical trials for genitourinary malignancies, particularly cancers of the bladder and prostate. Some of these trials have led to the approval of novel first-in-class cancer therapies.He has also presented his studies at numerous national and international cancer conferences and has published extensively in his field, with over 100 publications indexed on PubMed. He is a member of the American Society of Clinical Oncology, the European Society for Medical Oncology and the NRG Oncology Genitourinary Committee. He is also an editorial reviewer for the publicationsBladder CancerandAnnals of Case Reports. Dr. Kalebasty is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Kalebasty is board certified in American Board Of Internal Medicine - Medical Oncology.

Estelamari Rodriguez is an Oncologist practicing medicine in Miami, Florida. Dr. Rodriguez is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Rodriguez is currently accepting new patients.

John C. Krauss, M.D., graduated from the University of Michigan Medical School in 1985, did his Internal Medicine training at the University of Minnesota, and then returned to the University of Michigan for his Hematology and Oncology specialty training. Dr. Krauss joined the University of Michigan Faculty in 1992, and then moved his research lab to the Cleveland Clinic to continue clinical research on harnessing the immune system to combat cancer. In 1998, Dr. Krauss came back to Ann Arbor to be the Associate Director of the Ann Arbor Community Cancer Oncology Program at St. Joseph Mercy Hospital, and rose through the ranks to be the Section Head of Hematology/Oncology. Dr. Krauss treats a wide variety of patients with cancer, including breast cancer, colon cancer, lung cancer, and kidney cancer, focusing both on providing the highest possible cure rates for cancer and the best quality of life for the patient while on the journey. Dr. Krauss is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Squamous Cell Carcinoma of the Anal Canal (SCAC). Dr. Krauss is board certified in Internal Medicine and Medical Oncology. Dr. Krauss is currently accepting new patients.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy. Dr. Gartrell is currently accepting new patients.

Jeffrey Margolis is an Oncologist practicing medicine in Royal Oak, Michigan. Dr. Margolis is highly rated in 65 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Margolis is board certified in American Board Of Internal Medicine. Dr. Margolis is currently accepting new patients.

"Andrew Menzin, MD, is an OB/GYN and oncology specialist at Northwell Health Physician Partners Gynecologic Oncology at New Hyde Park. He is also the chief of gynecologic oncology for Northwell facilities across central Long Island and Queens, and the vice chairman of academic affairs for the OB/GYN service line. Dr. Menzin has nearly three decades of experience in gynecologic oncology and academic medicine.""I come from a family of doctors,"" he says. ""Education, medicine and service to others was just part of how I grew up.""Dr. Menzin treats the full spectrum of gynecologic issues, from benign conditions to all malignancies of the female reproductive system. His extensive surgical expertise includes cancer surgery, robotic surgery and complex gynecologic surgery.He joined Northwell Health in 1995, after completing a fellowship in gynecologic oncology and a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania.""At Northwell, we're here to meet every patient's needs and deliver truly collaborative care,"" says Dr. Menzin, who works closely with specialists including pathologists, radiologists, medical oncologists, radiation oncologists, general surgeons, colorectal surgeons and urologists. He carefully explains this multifaceted care to each patient-even drawing his unique diagrams for extra clarity.Dr. Menzin is a professor of obstetrics and gynecology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a member of the Society of Gynecologic Oncology, as well as a fellow of the American College of Surgeons and the American College of Obstetricians and Gynecologists. He's been named numerous times on the Castle Connolly Top Doctors list, and he's an avid supporter of the National Ovarian Cancer Coalition, which supports ovarian cancer survivors and funds research to find a cure.""I have had great mentors who've inspired me along the way,"" says Dr. Menzin. ""It's all about delivering care that's patient-centered. Looking after them the way I'd want to be cared for.""". Dr. Menzin is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Lymphadenectomy. Dr. Menzin is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology. Dr. Menzin is currently accepting new patients.

Ioana Hinshaw is an Oncologist practicing medicine in Denver, Colorado. Dr. Hinshaw is highly rated in 65 conditions, according to our data. Her clinical expertise encompasses Bone Tumor, Adult Soft Tissue Sarcoma, Paget Disease of the Breast, and Myxoid Liposarcoma. Dr. Hinshaw is board certified in American Board Of Internal Medicine. Dr. Hinshaw is currently accepting new patients.

Jonathan Kaufman is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Kaufman is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Multiple Myeloma, Primary Amyloidosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kaufman is board certified in American Board Of Internal Medicine, 2005. Dr. Kaufman is currently accepting new patients.

Ahmed Ghazi is an associate professor of urology at the Johns Hopkins University School of Medicine. He is the Director of Surgical Simulation Training and the Division of Minimally Invasive and Robotic Surgery within the Johns Hopkins Brady Urological Institute. Dr. Ghazi specializes in urologic surgical oncology using the latest techniques of minimally invasive surgery for prostate, kidney, bladder, ureteral and other genitourinary organ cancers. He also as specializes in minimal invasive treatment of complex stones of the urinary tract. Dr. Ghazi is a pioneer in the field of patient-specific surgical simulation, which has applications for training future surgeons as well as improving outcomes for patients through individualized modeling. When planning for a complex surgery, Dr. Ghazi constructs 3D models of the patient’s anatomy in order to plan and rehearse surgery prior to the actual surgery. These models span from digital renderings to tangible models used to practice the critical components of your surgery. Dr. Ghazi received his medical degree from Cairo University in Egypt in 2000, where he also completed his surgery training and urology residency. From there, Dr. Ghazi completed a laparoscopic fellowship in Paris, France in 2008, followed by a second laparoscopic fellowship in Austria in 2009. While practicing in Europe, Dr. Ghazi was accepted to the European Board of Urology. Dr. Ghazi continued his training at the University of Rochester, New York through a two-year fellowship in the robotic treatment of various urologic cancers. He then joined the staff at the urology department of University of Rochester in 2012 where he continued to practice until joining Johns Hopkins Medicine. Dr. Ghazi believes in a reciprocal relationship between innovation, surgery & research where each informs and strengthens the others. He strives to adopt innovative surgical technologies that are evidence-based, benefit his patients and translate directly to improved patient outcomes. Dr. Ghazi is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Boils, Muscle Invasive Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Ghazi is board certified in American Board Of Urology. Dr. Ghazi is currently accepting new patients.

Philip Lammers is a Hematologist Oncology specialist and a Hematologist practicing medicine in Bartlett, Tennessee. Dr. Lammers is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Lammers is currently accepting new patients.